CommercialLife Sciences Voice In Collaboration With Future Pharma EU...

Life Sciences Voice In Collaboration With Future Pharma EU 2026

-

Future Pharma Europe returns on 20–21 October 2026 in Amsterdam, bringing together senior commercial, marketing, digital and customer engagement leaders from Europe’s leading pharmaceutical and biotech companies for two days of practical learning, meaningful networking and collaborative discussion.

Designed specifically for commercial teams, the event moves beyond traditional presentations with interactive workshops, peer-led roundtables and real-world case studies that explore the latest strategies transforming pharmaceutical engagement.

You’ll gain practical insights into topics including:

  • AI-powered commercial transformation
  • Omnichannel HCP engagement
  • Commercial excellence and sales effectiveness
  • CRM innovation and customer engagement
  • Content personalisation at scale
  • Data, analytics and actionable customer insights
  • Breaking down silos between commercial, marketing and medical affairs
  • Digital innovation and customer experience

Join senior decision-makers from many of Europe’s leading pharmaceutical and biotech organisations, including Sanofi, Novo Nordisk, Takeda, Merck, GSK, Johnson & Johnson, AstraZeneca, Biogen, Teva, Recordati, Shionogi, Astellas Pharma, Kyowa Kirin, Galderma, Viatris, Ferring Pharmaceuticals, Fresenius Kabi, Menarini Group and other major global and regional life sciences companies.

Whether you’re looking to discover new technologies, benchmark your commercial strategy, learn from industry peers or build valuable new connections, Future Pharma Europe offers the insights and networking opportunities to help you stay ahead in an increasingly competitive market.

Register now to save 10% and join Europe’s leading pharmaceutical commercial, marketing and digital leaders this October for two days of practical insight, peer exchange and interactive learning: https://tinyurl.com/bdh3nycx

Latest news

The Economics of Decentralized Clinical Trials

Executive Summary Decentralized clinical trials are changing how pharmaceutical companies think about the economics of clinical research. Traditional trials often require...

Top 10 AI Investments Delivering the Highest ROI in Pharma

Executive Summary Artificial intelligence (AI) is becoming a strategic investment priority for pharmaceutical companies seeking to improve productivity, accelerate drug...

Top 10 Drivers Behind Site-less Clinical Trials

Executive Summary Clinical trials are moving beyond the traditional model in which participants repeatedly visit research sites for assessments, monitoring,...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you